{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:16Z","timestamp":1786985596561,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Higher Education Commission"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.cancergencyto.2010.03.017","type":"journal-article","created":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T04:56:10Z","timestamp":1279083370000},"page":"57-61","source":"Crossref","is-referenced-by-count":3,"title":["A unique BCR\u2013ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study"],"prefix":"10.1016","volume":"201","author":[{"given":"Hajra","family":"Sadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina T.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Nasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.03.017_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00062752-199807000-00010","article-title":"Chronic myeloid leukemia","volume":"5","author":"Deininger","year":"1998","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/geno.1995.1008","article-title":"Sequence and analysis of the human ABL gene, the BCR gene, and the regions involved in the Philadelphia chromosomal translocation","volume":"27","author":"Chissoe","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2141.1998.01043.x","article-title":"A novel BCR-ABL fusion gene (e2\/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course","volume":"103","author":"Byrne","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2141.1999.01640.x","article-title":"A novel BCR-ABL transcript e2a2 in a chronic myelogenous leukaemia patient with a duplicated Ph-chromosome and monosomy 7","volume":"106","author":"Leibundgut","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1365-2141.2000.02394.x","article-title":"Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantation","volume":"111","author":"Roman","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib6","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood.V88.6.2236.bloodjournal8862236","article-title":"A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia","volume":"88","author":"Hochhaus","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.2000.02042.x","article-title":"A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia","volume":"109","author":"Branford","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ajh.20138","article-title":"Second case of CML with aberrant BCR-ABL fusion transcript (e8\/a2) with insertion of an inverted ABL intron 1b sequence","volume":"77","author":"Sugimoto","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cancergencyto.2008.06.001","article-title":"A case of chronic myelogenous leukemia with e8a2 fusion transcript","volume":"185","author":"Park","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajh.10456","article-title":"Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory","volume":"75","author":"Snyder","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0950-3536(97)80003-0","article-title":"BCR-ABL gene variants","volume":"10","author":"Melo","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib12","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood.V97.11.3668","article-title":"A novel BCR-ABL fusion transcript (e15a2) in 2 patients with atypical chronic myeloproliferative syndrome","volume":"97","author":"Moreno Mdel","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib13","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","article-title":"Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction)","volume":"88","author":"Pane","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib14","first-page":"493","article-title":"The e19a2 bcr\/abl breakpoint in acute lymphoblastic leukaemia","volume":"110","author":"Rotoli","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib15","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","article-title":"The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype","volume":"88","author":"Melo","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib16","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.V85.9.2632.bloodjournal8592632","article-title":"Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients","volume":"85","author":"Radich","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib17","series-title":"ISCN 2009: an international system for human cytogenetic nomenclature (2009)","year":"2009"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib18","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.leu.2401509","article-title":"Concomitant expression of the rare E1\/A3 and B2\/A3 types of BCR\/ABL transcript in a chronic myeloid leukemia (CML) patient","volume":"13","author":"Martinelli","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.03.017_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2141.1997.d01-2066.x","article-title":"A novel acute lymphoid leukaemia type BCR\/ABL transcript in chronic myelogenous leukaemia","volume":"96","author":"Okamoto","year":"1997","journal-title":"Br J Haematol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810001974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810001974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T19:36:17Z","timestamp":1591472177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810001974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0165460810001974"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.03.017","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}